Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial

Por Lester, J.E., Dodwell, D., Brown, J.E., Purohit, O.P., Gutcher, S.A., Ellis, S.P., Thorpe, R., Horsman, J.M., Coleman, R.E.
Publicado no J Bone Oncol (2012)

Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival in Extremity Soft Tissue Sarcoma Patients Undergoing Surgery: An NCDB Analysis

Por Gingrich, Alicia A., Bateni, Sarah B., Monjazeb, Arta M., Darrow, Morgan, Thorpe, Steven W., Kirane, Amanda R., Bold, Richard J., Canter, Robert J.
Publicado no Ann Surg Oncol (2017)

Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125

Por Schummer, Michèl, Drescher, Charles, Forrest, Robin, Gough, Shirley, Thorpe, Jason, Hellström, Ingegerd, Hellström, Karl Erik, Urban, Nicole
Publicado em 2011

Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule

Por Drescher, Charles W., Shah, Chirag, Thorpe, Jason, O'Briant, Kathy, Anderson, Garnet L., Berg, Christine D., Urban, Nicole, McIntosh, Martin W.
Publicado em 2013

Identifying post-menopausal women at elevated risk for epithelial ovarian cancer

Por Urban, Nicole, Hawley, Sarah, Janes, Holly, Karlan, Beth Y., Berg, Christine D., Drescher, Charles W., Manson, JoAnn E., Palomares, Melanie R., Daly, Mary B., Wactawski-Wende, Jean, O’Sullivan, Mary J., Thorpe, Jason, Robinson, Randal D., Lane, Dorothy, Li, Christopher I., Anderson, Garnet L.
Publicado no Gynecol Oncol (2015)

Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy

Por Hulshoff, J. B., Faiz, Z., Karrenbeld, A., Kats-Ugurlu, G., Burgerhof, J. G. M., Smit, J. K., Plukker, J. Th. M.
Publicado no Ann Surg Oncol (2015)

Extent of Lymphadenectomy in Esophageal Cancer: How Many Lymph Nodes Is Enough?

Por Herrera, Luis J.
Publicado em 2009

Risk of Thromboembolic Events after Perioperative Chemotherapy Versus Surgery Alone for Esophageal Adenocarcinoma

Por Verhage, Roy J. J., van der Horst, Sylvia, van der Sluis, Pieter C., Lolkema, Martijn P. J. K., van Hillegersberg, Richard
Publicado em 2011

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?

Por Schreurs, L. M. A., Janssens, A. C. J. W., Groen, H., Fockens, P., van Dullemen, H. M., van Berge Henegouwen, M. I., Sloof, G. W., Pruim, J., van Lanschot, J. J. B., Steyerberg, E. W., Plukker, J. Th. M.
Publicado no Ann Surg Oncol (2011)

Oncologic Long-Term Results of Robot-Assisted Minimally Invasive Thoraco-Laparoscopic Esophagectomy with Two-Field Lymphadenectomy for Esophageal Cancer

Por van der Sluis, P. C., Ruurda, J. P., Verhage, R. J. J., van der Horst, S., Haverkamp, L., Siersema, P. D., Borel Rinkes, I. H. M., ten Kate, F. J. W., van Hillegersberg, R.
Publicado no Ann Surg Oncol (2015)

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review

Por Omloo, J. M. T., van Heijl, M., Hoekstra, O. S., van Berge Henegouwen, M. I., van Lanschot, J. J. B., Sloof, G. W.
Publicado em 2012

Treatment and Survival Differences in Older Medicare Patients With Lung Cancer as Compared With Those Who Are Dually Eligible for Medicare and Medicaid

Por Bradley, Cathy J., Dahman, Bassam, Given, Charles W.
Publicado em 2008

Decreased survival after combining thoracic irradiation and an anti-PD-1 antibody is correlated...

Por Myers, Carey J, Lu, Bo
Publicado no Int J Radiat Oncol Biol Phys (2017)

Hyperthermic Intra-Thoracic Chemotherapy (HITeC) for the management of recurrent ovarian cancer involving the pleural cavity

Por Singh, S., Armstrong, A., Robke, J., Waggoner, S., Debernardo, R.
Publicado no Gynecol Oncol Case Rep (2014)

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non–Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials

Por Langer, Corey J., Socinski, Mark A., Patel, Jyoti D., Sandler, Alan B., Schiller, Joan H., Leon, Larry, Hazard, Sebastien J., Ramalingam, Suresh S.
Publicado no Am J Clin Oncol (2016)

Impact of Endoscopic Ultrasonography on (18)F-FDG-PET/CT Upfront Towards Patient Specific Esophageal Cancer Treatment

Por Hulshoff, J. B., Mul, V. E. M., de Boer, H. E. M., Noordzij, W., Korteweg, T., van Dullemen, H. M., Nagengast, W. B., Oppedijk, V., Pierie, J. P. E. N., Plukker, John Th. M.
Publicado no Ann Surg Oncol (2017)

Retrospective analysis of artifacts in four-dimensional CT images of 50 abdominal and thoracic radiotherapy patients

Por Yamamoto, Tokihiro, Langner, Ulrich, Loo, Billy W., Shen, John, Keall, Paul J.
Publicado em 2008

Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer

Por Visser, E., Leeftink, A. G., van Rossum, P. S. N., Siesling, S., van Hillegersberg, R., Ruurda, J. P.
Publicado no Ann Surg Oncol (2016)

Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment

Por Kilburn, Jeremy M., Kuremsky, Jeffrey G., Blackstock, A. William, Munley, Michael T., Kearns, William T., Hinson, William H., Lovato, James F., Miller, Antonius A., Petty, William J., Urbanic, James J.
Publicado em 2014

Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent

Por Parry, K., Visser, E., van Rossum, P. S. N., Mohammad, N. Haj, Ruurda, J. P., van Hillegersberg, R.
Publicado no Ann Surg Oncol (2015)